Sonochemical synthesis of calcium phosphate powders.

beta-tricalcium phosphate (beta-TCP) and biphasic calcium phosphate powders (BCP), consisting of hydroxyapatite (HA) and beta-TCP, were synthesized by thermal decomposition of precursor powders obtained from neutralization method. The precursor powders with a Ca/P molar ratio of 1.5 were prepared by adding an orthophosphoric acid (H(3)PO(4)) solution to an aqueous suspension containing calcium hydroxide (Ca(OH)(2)). Mixing was carried out by vigorous stirring and under sonochemical irradiation at 50 kHz, respectively. Glycerol and D-glucose were added to evaluate their influence on the precipitation of the resulting calcium phosphate powders. After calcination at 1000 degrees C for 3 h BCP nanopowders of various HA/beta-TCP ratio were obtained.

In vivo evaluation of hydroxyapatite foams.

Hydroxyapatite (HA) is widely applied as bone graft material due to its osteoconductive potential and well-established biocompatibility. In this work, macroporous hydroxyapatite structures made through foaming of aqueous suspensions and gelcasting were tested for in vivo osteointegration. These foams are composed of a three-dimensional array of spherical pores with diameters of approximately 100-500 microm, interconnected by windows of smaller size in the range of 30-120 microm. The HA foams were implanted in the tibia of albino New Zealand rabbits and removed after a period of 8 weeks. Histological analysis revealed that the pores in the foams were partially or completely filled progressively with mature new bone tissue and osteoid after the implanted period. No immune or inflammatory reactions were detected. The high osteoconductive potential of the HA foams provides a potential structure for use as bone substitute in orthopedic, oral, and cranio-maxillofacial reconstructive surgery, and as dento-alveolar implants.

Use of steel converter slag as nickel adsorber to wastewater treatment.

Magnetite, the main component of converter slag in the steel industry, can be used for the adsorption of Ni(II) from aqueous solutions, over a range of conditions: initial metal concentration (10-100 mg 1(-1)), stirring times (2-240 min), adsorbent dosage (1 g for 0.5 1 of metal solution) and temperatures (20, 30 and 38 degrees C). The adsorption rate increased with initial concentration but decreased with increase in temperature, due to competition of the dissolution process. The adsorption process obeyed the Freundlich isotherm model.

Production of porous hydroxyapatite by the gel-casting of foams and cytotoxic evaluation.

This study presents the manufacture of highly porous hydroxyapatite by a novel technique that employs the foaming of suspensions prior to the in situ polymerization of organic monomers contained in the compositions. This method produces strong gelled bodies with up to 90% porosity that can withstand machining in the green state. Complex-shaped components can be obtained if the process comprises casting in one of the processing steps. The organic additives are eliminated at temperatures above 300 degrees C, and sintering is carried out for consolidation of the ceramic matrix. Spherical interconnected cells with sizes ranging from 20 to 1000 micrometer characterize the porous structure, depending on the specimen density. Cytotoxicity tests were conducted on extracts from sintered HA foams based on a quantitative method of cell colony formation and the determination of cell death after indirect contact of the porous material with mammalian cells. This in vitro test of biological evaluation revealed that the original purity of the biomedical-grade hydroxyapatite powder was affected neither through processing nor by the employed reagents.

The interaction of blood proteins with alpha-alumina.

The use of alumina (alpha-Al2O3) as a material for cardiovascular applications was investigated on the basis of protein adsorption and thrombus formation on the material. The adsorption of 125I-labelled albumin and fibrinogen from phosphate buffered saline (pH 7.35, 0.100 M NaCl, 8.66 mM KH2PO4 and 41 mM Na2HPO4) solution on ceramic discs of alumina was studied. Both albumin and fibrinogen presented affinity for ceramic surfaces, with adsorptions of 1.47 +/- 0.06 ng/cm2 and 0.198 +/- 0.01 ng/cm2, respectively. Scanning electron micrographs of the alpha-Al2O3 surfaces after contact of the discs with whole human blood showed a thrombogenic behavior of alumina alpha. These results indicate a hemoincompatible property. Although critical surface tension (gamma C: 21.8 dynes/cm) of the disc surfaces determined by contact angle technique of sessile drops indicates that alumina alpha is a biocompatible material, by this criterion, the data reported here indicate that alpha-Al2O3 cannot be used for cardiovascular applications.

The interation of blood proteins with alpha-alumina

The use of alumina (Ó-Al2O3) as a material for cardiovascular applications was investigated on the basis of protein adsorption and thrombus formation on the material. The adsorption of 125I-labelled albumin and fibrinogen from phosphate buffered saline (pH 7.35, 0.100 M NaCl, 8.66 mM KH2PO4 and 41 mM Na2HPO4) solution on ceramic discs of alumina was studied. Both albumin and fibrinogen presented affinity for ceramic surfaces, with adsorptions of 1.47 + or - 0.6 ng/cm2 and 0.198 + or - 0.01 ng/cm2, respectively. Scanning electron micrographs of the Ó-Al2O3 surfaces after contact of the discs with whole human blood showed a thrombogenic behavior of alumina alpha. These results indicate a hemoincompatible property. Although critical surface tension (YC: 21.8 dynes/cm) of the disc surfaces determined by contact angle technique of sessile drops indicates that alumina alpha is a biocompatible material, by this criterion, the data reported here indicate that Ó-Al2O3 cannot be used for cardiovascular applications